lidoflazine has been researched along with Auricular Flutter in 6 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-seven patients with chronic atrial fibrillation and (or) flutter in whom the clinical picture and the length of arrhythmia indicated that drug-mediated cardioversion should be tried were treated with a combination of lidoflazine and propafenon." | 7.66 | [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H, 1980) |
| " 30 patients (group I) received lidoflazine in increasing dosage up to 480 mg/24 h and in cases where there was no conversion to sinus rhythm propafenon in a maximal daily dosage of 1800 mg orally." | 6.64 | [Propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H; Lehmann, HU, 1978) |
| "The efficacy of quinidine versus lidoflazine therapy was compared in the maintenance of sinus rhythm after electrical cardioversion for atrial flutter or fibrillation in a group of 35 patients." | 5.04 | Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias. ( Kennelly, BM, 1977) |
| "Forty-seven patients with chronic atrial fibrillation and (or) flutter in whom the clinical picture and the length of arrhythmia indicated that drug-mediated cardioversion should be tried were treated with a combination of lidoflazine and propafenon." | 3.66 | [Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H, 1980) |
| " 30 patients (group I) received lidoflazine in increasing dosage up to 480 mg/24 h and in cases where there was no conversion to sinus rhythm propafenon in a maximal daily dosage of 1800 mg orally." | 2.64 | [Propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)]. ( Beck, OA; Hochrein, H; Lehmann, HU, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck, OA | 2 |
| Hochrein, H | 3 |
| Hůla, J | 1 |
| Pelechová, J | 1 |
| Fikrle, A | 1 |
| Kennelly, BM | 1 |
| Abaza, A | 1 |
| Joly, H | 1 |
| Dellattre, G | 1 |
| Ouhioun, A | 1 |
| Garnier, JC | 1 |
| Aziza, C | 1 |
| Lehmann, HU | 2 |
3 trials available for lidoflazine and Auricular Flutter
| Article | Year |
|---|---|
Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Death, Sudden; Drug Admi | 1977 |
[Propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Female; Humans; | 1978 |
[Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
Topics: Aged; Arteriosclerosis; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Electrocardio | 1975 |
3 other studies available for lidoflazine and Auricular Flutter
| Article | Year |
|---|---|
[Combined use of propafenon and lidoflazine in chronic atrial fibrillation and flutter (author's transl)].
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Chronic Disease; Drug Therapy, Co | 1980 |
[The significance of lidoflazine in the therapy of atrial fibrillation and flutter].
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Humans; Lidoflazine; Middle Aged; Piperazines | 1984 |
[Auricular arrhythmias: conversion to sinus rhythm by a lidoflazine-potassium compound].
Topics: Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Humans; Lidoflazine; Piperazines; Po | 1978 |